Capricor Therapeutics (CAPR) Institutional Ownership $13.07 +0.17 (+1.32%) (As of 12/20/2024 05:40 PM ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Capricor Therapeutics (NASDAQ:CAPR)CurrentInstitutional OwnershipPercentage21.68%Number ofInstitutional Buyers(last 12 months)20TotalInstitutional Inflows(last 12 months)$14.21MNumber ofInstitutional Sellers(last 12 months)3TotalInstitutional Outflows(last 12 months)$201.29K Get CAPR Insider Trade Alerts Want to know when executives and insiders are buying or selling Capricor Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data CAPR Institutional Buying and Selling by Quarter Ad Brownstone ResearchMissed Nvidia? Buy Elon Musk’s “Silent Partner”In February 2016, when almost nobody was talking about artificial intelligence… I picked Nvidia as one of my favorite stocks. Today, it’s probably the most popular stock in the world. I believe this Elon Musk “silent partner” could be the next big AI winner.So please click here to see the details because a lot of people could get rich. Capricor Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/20/2024 Virtu Financial LLC30,112$458K0.0%N/A0.066% 11/19/2024 Barclays PLC36,296$552K0.0%+106.6%0.080% 11/16/2024 Geode Capital Management LLC638,189$9.71M0.0%-0.5%1.405% 11/15/2024 Barclays PLC36,296$552K0.0%+106.6%0.080% 11/15/2024 Sphera Funds Management LTD.61,698$938K0.1%N/A0.136% 11/15/2024 State Street Corp512,313$7.79M0.0%+27.8%1.128% Get the Latest News and Ratings for CAPR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Capricor Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/15/2024 Sassicaia Capital Advisers LLC12,600$192K0.6%N/A0.028% 11/15/2024 Point72 Asset Management L.P.250,204$3.81M0.0%N/A0.551% 11/14/2024 PFM Health Sciences LP152,779$2.32M0.1%N/A0.336% 11/14/2024 Fred Alger Management LLC26,241$399K0.0%N/A0.058% 11/13/2024 BNP Paribas Financial Markets17,699$269K0.0%+868.7%0.039% 11/13/2024 FMR LLC24,344$370K0.0%N/A0.054% 11/13/2024 The Manufacturers Life Insurance Company10,558$161K0.0%N/A0.023% 11/12/2024 Activest Wealth Management5,000$76K0.0%-50.0%0.011% 11/6/2024 Main Street Financial Solutions LLC22,650$345K0.0%-17.6%0.050% 11/6/2024 Oppenheimer & Co. Inc.68,408$1.04M0.0%+25.2%0.151% 10/3/2024 SG Americas Securities LLC8,765$133K0.0%N/A0.027% 8/14/2024 Marshall Wace LLP89,314$426K0.0%N/A0.279% 8/9/2024 Renaissance Technologies LLC137,500$656K0.0%+158.7%0.430% 8/8/2024 Main Street Financial Solutions LLC27,500$131K0.0%+37.5%0.086% 8/1/2024 Rhumbline Advisers30,886$147K0.0%N/A0.097% 7/26/2024 Bank of New York Mellon Corp79,782$381K0.0%+12.8%0.249% 5/10/2024 Vanguard Group Inc.1,365,903$9.27M0.0%+17.2%4.336% 5/1/2024 BNP Paribas Financial Markets5,827$40K0.0%N/A0.018% 2/7/2024 Jump Financial LLC52,800$258K0.0%N/A0.171% 12/6/2023 Citigroup Inc.61,591$211K0.0%N/A0.200% 7/31/2023 LPL Financial LLC78,436$375K0.0%N/A0.310% 5/1/2023 Virtu Financial LLC16,895$71K0.0%N/A0.067% 11/7/2022 Jump Financial LLC22,600$136K0.0%N/A0.093% 10/18/2022 Bailard Inc.33,601$202K0.0%+12.8%0.138% 7/27/2022 Bailard Inc.29,801$104K0.0%N/A0.123% 4/20/2022 Selective Wealth Management Inc.213,494$732K0.3%N/A0.878% 11/16/2021 Two Sigma Securities LLC11,511$46K0.0%N/A0.050% 11/15/2021 GSA Capital Partners LLP96,632$388K0.0%-14.0%0.420% 11/15/2021 HighTower Advisors LLC53,960$215K0.0%+206.6%0.234% 11/9/2021 Barclays PLC6,330$25K0.0%+246.1%0.027% 11/9/2021BlackRock Inc.300,201$1.21M0.0%-1.6%1.304% 8/17/2021 Oracle Investment Management Inc.1,166,249$5.98M0.8%-41.7%5.098% 8/16/2021 State Street Corp71,748$368K0.0%N/A0.314% 8/13/2021 Northern Trust Corp104,251$535K0.0%+7.5%0.456% URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.Register for the FREE Workshop Now & get $10 in Bitcoin8/13/2021 Geode Capital Management LLC184,990$948K0.0%+7.9%0.809% 8/13/2021 Vanguard Group Inc.923,233$4.74M0.0%+1.2%4.035% 8/11/2021Susquehanna Fundamental Investments LLC16,500$85K0.0%-49.1%0.072% 8/5/2021 GSA Capital Partners LLP112,364$576K0.1%+684.6%0.491% 5/18/2021 Millennium Management LLC22,390$105K0.0%-54.6%0.098% 5/18/2021 Oracle Investment Management Inc.1,999,464$9.36M1.4%N/A8.770% 5/12/2021 Northern Trust Corp96,941$453K0.0%-29.1%0.425% 5/12/2021 M Holdings Securities Inc.20,000$94K0.0%N/A0.088% 5/12/2021 Geode Capital Management LLC171,415$802K0.0%+40.7%0.752% 5/10/2021 HighTower Advisors LLC12,300$57K0.0%-25.9%0.054% 5/10/2021 GSA Capital Partners LLP14,321$67K0.0%-81.9%0.063% 5/7/2021BlackRock Inc.347,103$1.62M0.0%+1.2%1.523% 5/3/2021Trellus Management Company LLC270,000$1.26M0.7%N/A1.184% 2/11/2021 Northern Trust Corp136,814$469K0.0%-9.6%0.669% 2/9/2021 Bank of New York Mellon Corp89,249$306K0.0%+47.7%0.436% 2/5/2021BlackRock Inc.343,011$1.18M0.0%+0.4%1.677% 2/4/2021 GSA Capital Partners LLP79,091$271K0.0%N/A0.387% 11/17/2020 Jane Street Group LLC12,943$68K0.0%-51.1%0.066% 11/13/2020 Morgan Stanley44,843$235K0.0%+26.4%0.227% 11/12/2020 JPMorgan Chase & Co.5,607$30K0.0%+80,000.0%0.028% 11/6/2020BlackRock Inc.341,523$1.79M0.0%+900.8%1.732% (Data available from 1/1/2016 forward) CAPR Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CAPR shares? During the previous two years, 24 institutional investors and hedge funds held shares of Capricor Therapeutics. The most heavily invested institutionals were Geode Capital Management LLC ($9.71M), Vanguard Group Inc. ($9.27M), State Street Corp ($7.79M), Point72 Asset Management L.P. ($3.81M), PFM Health Sciences LP ($2.32M), Oppenheimer & Co. Inc. ($1.04M), and Sphera Funds Management LTD. ($938K).Learn more on CAPR's institutional investors. What percentage of Capricor Therapeutics stock is owned by institutional investors? 21.68% of Capricor Therapeutics stock is owned by institutional investors. Learn more on CAPR's institutional investor holdings. Which institutional investors have been buying Capricor Therapeutics stock? Of the 22 institutional investors that purchased Capricor Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Point72 Asset Management L.P. ($250.20K), Vanguard Group Inc. ($200.50K), PFM Health Sciences LP ($152.78K), State Street Corp ($111.29K), Marshall Wace LLP ($89.31K), Renaissance Technologies LLC ($84.35K), and LPL Financial LLC ($78.44K). How much institutional buying is happening at Capricor Therapeutics? Institutional investors have bought a total of 1,392,812 shares in the last 24 months. This purchase volume represents approximately $14.86M in transactions. Which Capricor Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Capricor Therapeutics stock in the last 24 months: Activest Wealth Management ($5K), Main Street Financial Solutions LLC ($4.85K), and Geode Capital Management LLC ($3.38K). How much institutional selling is happening at Capricor Therapeutics? Institutional investors have sold a total of 13,234 shares in the last 24 months. This volume of shares sold represents approximately $201.29K in transactions. Related Companies CPRX Institutional Ownership AGIO Institutional Ownership PTGX Institutional Ownership AMRX Institutional Ownership LBPH Institutional Ownership LGND Institutional Ownership GERN Institutional Ownership NAMS Institutional Ownership IDYA Institutional Ownership CNTA Institutional Ownership This page (NASDAQ:CAPR) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Capricor Therapeutics Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Capricor Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
